期刊文献+

晚期肝内胆管细胞癌的转化医学综合治疗 被引量:1

Comprehensive treatment of advanced intrahepatic cholan- giocarcinoma with translational medicine
原文传递
导出
摘要 1临床资料患者男,62岁。因健康体检时发现肝脏包块1个月于2014年10月22日入院。患者无发热、恶心呕吐、食欲不振、腹痛腹胀、呕血黑便、尿色加深等不适。患者入院前2d于外院复查增强CT结果示:肝血管瘤可能性大;肝内多发囊性低密度病灶;左侧第10肋骨骨折,病理性骨折可能。既往有痛风和外伤性肋骨骨折病史,无肝炎肝硬化病史。无烟酒嗜好,无家族疾病遗传史。体格检查:BMI为24.4kg/m2;腹部无阳性体征。
出处 《中华消化外科杂志》 CAS CSCD 北大核心 2016年第4期401-403,共3页 Chinese Journal of Digestive Surgery
基金 沈阳市科学技术项目(F13-221-9-24)
关键词 胆道肿瘤 转化医学 综合治疗 Biliary neoplasms Translational medicine Comprehensive treatment
  • 相关文献

参考文献13

  • 1Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer [ J ]. N Engl J Med,2010,362(14) :1273-1281. DOI:10. 1056/NEJMoa0908721.
  • 2Morizane C, Okusaka T, Mizusawa J, et al. Randomized phase 11 study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer : a Japan Clinical Oacology Group trial ( JCOG 0805 ) [ J ]. Cancer Sci, 2013, 104 ( 9 ) : 1211-1216. DOI: 10. llll/cas. 12218.
  • 3Valle JW, Furuse J, Jitlal M, et al. Cisplatin and gemcitabine for advanced biIiary tract cancer: a meta-analysis of two randomised trials[ J ]. Ann Oncol,2014,25 (2) :391-398. DOI: 10. 1093/an- nonc/mdt540.
  • 4Brown KM, Pannar AD, Geller DA. Intrahepatic cholangiocarcino- ma[J]. Surg Oncol Clin N Am,2014,23(2):231-246. DOI:10. 1016/j. soc. 2013.10,004.
  • 5李景泽,汪慧,于凤海,胡和平,吴孟超.182例肝内胆管细胞癌临床病理分析[J].中华消化杂志,2008,28(2):121-122. 被引量:3
  • 6Bridgewater J, Galle PR, Khan SA, et al. Guideline.s for the diag- nosis and management of intrahepatic cholangiocarcinoma[J]. J Hepatol,2014,60 ( 6 ) : 1268-1289. DOI : 10. 1016/j. jhep. 2014. 01. 021.
  • 7Tabrizian P, Jibara G, Hechtman JF, et al. Outcomes following re- section of intrahepatic cholangiocarcinoma [ J ]. HPB ( Oxford), 2015,17(4) :31-4-351. DOI:10. llll/hpb. 12359.
  • 8Groot Koerkamp B, Fong Y. Outcomes in biliary malignancy [J]. J Surg Oncol,2014,110(5 ) :585-591. DOI:10. 1002/jso. 23762.
  • 9Bektas H, Yeyrek C, Kleine M, et al. Surgical treatment for intra- hepatic cholangiocarcinoma in Europe: a single center experience [J].J Hepatobiliary Pancreat Sci,2015,22(2):131-137. DOI: 10. 1002/jhbp. 158.
  • 10唐啸.根治性切除术辅助肝动脉化疗栓塞治疗肝内胆管细胞癌的疗效和预后分析[J].临床肝胆病杂志,2015,31(2):236-239. 被引量:12

二级参考文献37

  • 1Shaib YH, El-Serag HB, Davila JA, et al. Risk factors of intrahepatic cholangiocarcinoma in the United States: a casecontrol study. Gastroenterology, 2005, 128:620-626.
  • 2Weber SM, Jarnagin WR, Klimstra D, et al. Intrahepatic cholangiocarcinoma:resectability, recurrence pattern, and outcomes. J Am Coll Surg, 2001, 193:384-391.
  • 3Patel AH, Harnois DM, Klee GG, et al. The utility of CA 199 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol, 2000, 95: 204-207.
  • 4Malhi H, Gores GJ. Review artiele, the modern diagnosis and therapy of cholangiocarcinoma. Aliment Pharmacol Ther, 2006, 23;1287-1296.
  • 5McLean L, Patel T. Racial and ethnic variations in the epidemiol- ogy of intrahepatic cholangiocarcinoma in the United States [ J ]. Liver Int ,2006,26 (9) : 1047-1053.
  • 6Hsing AW, Gao YT, Devesa SS,et al. Rising incidence of biliary tract cancers in Shanghai, China[ J ]. Int J Cancer, 1998,75 (3) : 368-370.
  • 7Khan SA, Davidson BR, Goldin R, et al. British Society of Gas- troenteroln. Guidelines for the diagnosis and treatment of cholan- giocarcinoma : consensus document [ J ]. Gut,2002, Suppl 6 : VI1 - 9.
  • 8Matsuo K1, Rocha FG, he K, et al. the Blumgart preoperative staging system for hilar cholangiocarcinoma : analysis of resectabili- ty and outcomesin 380 patients [ J]. J Am Coll Surg,2012,215 (3) :343-355.
  • 9Hezel AF, Zhu AX. Systemic therapy for hiliary tract cancers [ J ]. Oncologist,2008,13 (4) :415-423.
  • 10Leonard GD, OReilly EM. Biliary tract cancers:cmTuent concepts and controversies [ J ]. Expert Opin Pharmacother, 2005,6 ( 2 ) : 211-223.

共引文献17

同被引文献7

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部